Document Detail


Effect of felbamate and its combinations with conventional antiepileptics in amygdala-kindled rats.
MedLine Citation:
PMID:  15159139     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
We investigated the effect of felbamate, administered singly and in combination with carbamazepine, phenobarbital, phenytoin or clonazepam, on various behavioral and electrographic correlates of seizures in amygdala-kindled rats. Felbamate (5 or 10 mg/kg) significantly increased afterdischarge threshold, shortened seizure and afterdischarge durations but remained without effect on seizure severity. Furthermore, the combination of felbamate (2.5 mg/kg) with carbamazepine (7.5 mg/kg; both drugs at their subeffective doses), was associated with the reduction in seizure severity and afterdischarge duration. In relation to the afterdischarge duration, the antiseizure potency of felbamate and carbamazepine, in combination, was comparable with that of carbamazepine (10 mg/kg) administered alone. Neither carbamazepine (7.5 and 10 mg/kg) nor felbamate (2.5-10 mg/kg) affected seizure severity, whereas the combined administration of felbamate (2.5 mg/kg) with carbamazepine (7.5 mg/kg) led to significant reduction in seizure severity from the fifth to the third stage of Racine's scale. Among the conventional antiepileptic drugs evaluated in this study, only valproate (100 mg/kg) and clonazepam (0.1 mg/kg) exerted similar action on seizure severity. However, the combinations of felbamate (2.5 mg/kg), with subeffective doses of valproate, phenobarbital, phenytoin or clonazepam, were not associated with any protective action. As blood and brain felbamate and carbamazepine concentrations were unaffected, a pharmacokinetic interaction can be excluded and a pharmacodynamic interaction concluded. These data suggest that felbamate and carbamazepine, administered in combination, may be useful in patients with drug-resistant partial epilepsy.
Authors:
K K Borowicz; N Ratnaraj; P N Patsalos; S J Czuczwar
Related Documents :
3349229 - Interactions of the imidazodiazepine ro 15-4513 with chemical convulsants.
2137409 - Anticonvulsant effects of dihydropyridine ca2+ antagonists in electrocortical shock sei...
22139909 - A phase 1 dose-escalation study of arry-520, a kinesin spindle protein inhibitor, in pa...
7542039 - The role of nitric oxide in modulating brain activity and blood flow during seizure.
17690949 - Brivaracetam is superior to levetiracetam in a rat model of post-hypoxic myoclonus.
20338539 - Neuropharmacological screening of two 1,5-benzodiazepine compounds in mice.
12382919 - Tl emission spectra from differently doped lif:mg detectors.
12385679 - Lower dose of ciprofloxacin is adequate for the treatment of neisseria gonorrhoeae in k...
3955199 - The pharmacokinetics of oral and intravenous prenalterol in young, healthy volunteers.
Publication Detail:
Type:  Comparative Study; Journal Article    
Journal Detail:
Title:  Pharmacology, biochemistry, and behavior     Volume:  78     ISSN:  0091-3057     ISO Abbreviation:  Pharmacol. Biochem. Behav.     Publication Date:  2004 May 
Date Detail:
Created Date:  2004-05-25     Completed Date:  2005-01-07     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  0367050     Medline TA:  Pharmacol Biochem Behav     Country:  United States    
Other Details:
Languages:  eng     Pagination:  103-10     Citation Subset:  IM    
Affiliation:
Department of Pathophysiology, Lublin Medical University, Jaczewskiego 8, Lublin 20-090, Poland. kornel@asklepios.am.lublin.pl
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Amygdala / drug effects*,  metabolism
Animals
Anticonvulsants / metabolism,  pharmacology*,  therapeutic use
Drug Interactions / physiology
Drug Therapy, Combination
Kindling, Neurologic / drug effects*,  physiology
Male
Phenylcarbamates
Propylene Glycols / metabolism,  pharmacology*,  therapeutic use
Rats
Rats, Wistar
Seizures / drug therapy,  metabolism
Chemical
Reg. No./Substance:
0/Anticonvulsants; 0/Phenylcarbamates; 0/Propylene Glycols; 25451-15-4/felbamate

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Intranasal cocaine in humans: acute tolerance, cardiovascular and subjective effects.
Next Document:  Normal spatial and contextual learning for ketamine-treated rats in the pilocarpine epilepsy model.